| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company®, today announced that Charles Meyers, President and CEO, will have a fireside chat at the J.P. Morgan 52nd Annual Global...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
ADP (Nasdaq: ADP), a leading global technology company providing human capital management (HCM) solutions, today announced that members of its management team will present at the following...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
CEO David J. Bearss, Ph.D., will be participating in a panel discussing the "Landscape of Drug Discovery and Impact of AI Discussion" on Wednesday, May 22, from 1:50 to 2:30 p.m. CEST Company...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
On June 30, 2024, Brain-CA Technologies, Inc. will introduce a new, patented AI solution based on Cellular Automata that will revolutionize the AI industry. This new technology paves the way for...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
Preeminent industry event hosts nearly 2,000 Advisors, RIAs, Enterprises and Fintechs who Seek Better Client Outcomes, Growth and Productivity through Envestnet's Wealth Management Platform...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
̶ Results from Long-Term Safety Study and Data from Healthcare Resource Utilization Research Offer Insights into Treatment Experiences for People Living with Schizophrenia or Bipolar I Disorder...
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
In collaboration with leading cancer centers, research results to be presented from 41 studies across 19 solid tumor types demonstrating Caris' impact on precision medicine IRVING, Texas, May 14, 2024
-
May 14, 2024Virtual Press Office and PR Newswire: General Trade show news
BSV DevCon is inviting blockchain enthusiasts, professionals, entrepreneurs, and innovators for a day of insightful sessions, hands-on workshops, and networking opportunities. Set to take place on...
